IntroductionThis short communication seeks to highlight the link between thyroid disease and bone fragility. Short CommunicationBone remodelling/metabolism involve a homeostatic balance between formation (osteoblastic) and resorption (osteoclastic). This balance is regulated by bone regulatory molecules, including receptor activator of nuclear factor-κ B and osteoprotegerin. Conclusion Elevated thyroid hormone may lead to increased bone resorption activities, which may lead to an increased risk of osteopenia and osteporotic fractures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.